Marksans Pharma Ltd
As of 20 Nov 2026, Marksans Pharma is in Stage 3, the topping phase, now in its first week (since 16 Nov 2026). It closed at ₹291, 16.2% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the Uni… More about the company
Pro read
ProMARKSANS's uptrend is tiring: in its first week into a top. A topping stock either breaks back out or rolls over into a decline, and the next few weeks usually settle which.
Its relative strength is 91 of 99, a leader among NSE stocks over the past year. Pharmaceuticals ranks 7 of 106 industries by the strength of its stocks, among the leaders.
Is MARKSANS early, or has it already run? Pro answers that for every NSE stock, after every close.
MARKSANS among Pharmaceuticals27th of 118 by relative strength
All 118 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | BLISSGVS | Stage 2 · wk 49 | 99 | +4.6% |
| 2 | KPL | Stage 2 · wk 44 | 99 | +20.5% |
| 3 | FREDUN | Stage 2 · wk 33 | 98 | +24.0% |
| 4 | VENUSREM | Stage 3 · wk 10 | 98 | −1.5% |
| 5 | RUBICON | Stage 3 · wk 4 | 98 | +18.7% |
| 6 | SAKAR | Stage 2 · wk 55 | 98 | +13.1% |
| 7 | BAFNAPH | Stage 2 · wk 23 | 98 | +1.9% |
| 8 | INDSWFTLAB | Stage 2 · wk 23 | 98 | −7.4% |
| …27 | MARKSANS | Stage 3 · wk 1 | 91 | −2.3% |
Mutual fund holdings
Held by 20 mutual funds in portfolios to October 2026: 13 active funds and 7 index funds and ETFs.
In October, among active funds: 2 increased, 3 opened a new position and 4 reduced.
All 20 funds and what each did in October
Mutual funds holding MARKSANS: the ten largest and the month’s moves →
Marksans Pharma: quick answers
What stage is Marksans Pharma in?
As of 20 Nov 2026, Marksans Pharma (MARKSANS) is in Stage 3, the topping phase. It entered Stage 3 on 16 Nov 2026 and is in its first week there. What the four stages mean
Is Marksans Pharma in an uptrend?
Its uptrend has stalled. Marksans Pharma is in Stage 3, the topping phase that follows an advance. It trades 16.7% above its 200-day average, which is rising.
How far is Marksans Pharma from its 52-week high?
Marksans Pharma closed at ₹291 on 20 Nov 2026, 16.2% below its 52-week high of ₹348. Its 52-week low is ₹157.
How has Marksans Pharma performed over the past year?
As of 20 Nov 2026, Marksans Pharma is up 54.6% over the past year and up 61.5% so far in 2026.
Which sector and industry is Marksans Pharma in?
Marksans Pharma is in the Pharmaceuticals industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Pharmaceuticals
About this companyHealth Care· Pharmaceuticals
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.